ALNY insider trading
Alnylam Pharmaceuticals, Inc. · end-of-day data as of Oct 16, 2026
Alnylam Pharmaceuticals, Inc.
$231.83-14.7%
Buy · 30 analystsPT $374.49 +61.5%
In the last 12 months ALNY insiders made 0 open-market purchases and 34 sales worth $43.95M, as reported on SEC Form 4. The latest: SUPRAN BRYAN (officer: EVP, CLO and Secretary) sold 1,758 shares at $226.88 on Oct 2, 2026.
Last 90 days
- Insiders-$399K
Transactions
Open-market buys $0 · sells $43.95M over the last 365 days (0 buys, 34 sells).
| Oct 2, 2026 | SUPRAN BRYAN | Sell | 1,758 | $226.88 | $399K |
| Sep 19, 2026 | Greenstreet Yvonne | Other | 107 | — | — |
| Jun 1, 2026 | Cravatt Benjamin | Other | 4,393 | $295.63 | $1.3M |
| Jun 1, 2026 | PYOTT DAVID E I | Other | 7,660 | $70.20 | $269K |
| Jun 1, 2026 | PYOTT DAVID E I | Sell | 3,830 | $299.18 | $1.15M |
| May 20, 2026 | Arbuckle Stuart A | Other | 2,112 | $298.48 | $430K |
| May 20, 2026 | Ausiello Dennis A | Other | 2,112 | $298.48 | $430K |
| May 20, 2026 | BRANDICOURT OLIVIER | Other | 2,112 | $298.48 | $430K |
| May 20, 2026 | HAMBURG MARGARET A | Other | 2,112 | $298.48 | $430K |
| May 20, 2026 | KELLOGG PETER N | Other | 2,112 | $298.48 | $430K |
| May 20, 2026 | PYOTT DAVID E I | Other | 2,112 | $298.48 | $430K |
| May 20, 2026 | Reitan Colleen F | Other | 2,112 | $298.48 | $430K |
| May 20, 2026 | SCHULMAN AMY W | Other | 2,640 | $298.48 | $538K |
| May 20, 2026 | Sigal Charles Elliott | Other | 2,112 | $298.48 | $430K |
| May 13, 2026 | SCHULMAN AMY W | Other | 22,500 | $70.20 | $1.58M |
| Apr 6, 2026 | McLaughlin Melissa | Sell | 2,286 | $330.42 | $755K |
| Apr 2, 2026 | McLaughlin Melissa | Sell | 1,624 | $319.59 | $519K |
| Mar 25, 2026 | McLaughlin Melissa | Other | 3,567 | $325.07 | $1.16M |
| Mar 5, 2026 | Fitzgerald Kevin Joseph | Sell | 658 | $323.98 | $213K |
| Mar 5, 2026 | Garg Pushkal | Sell | 2,404 | $323.96 | $779K |
Source: SEC Form 4 filings. "Other" covers awards, option exercises and gifts.